An FDA Act that may be relvant to ATL-1102 FDA, page-133

Yes i do, but if u look at anp attention n track record. Thats not the case. One of biggest American for dmd don't want this to succeed. They want gene therapy technology to work or hold the market or its the new cool thing in town thats gets all the money or investment.

pharmacy company would like to see more grounds grounds. If aef could hold this off from going to 15c then there isn't enough interest into anp because of 2 years and lack of controls.

yes anp once completed 2b then it will get more interest.

thats why the fda means absolutely nothing, it was a fluff announcement to try get the share price to shoot.

because that only matters when anp has finished phase 2b.

yes they could dive into a partnership and then holders will lose most of there wealth or or.

just doing a last CR to get enough funding for phase 2b and 3 years of operation cost.

then that will be the best because a 2 year wait is a fair amount of time you going be waiting for and want the best return for your money.